Lobbying Filing Details

Total Spending

$60,000

Activities

2

Lobbyists

2

Gov't Entities

6

Filing Information
Filing UUID:
77a79326-9a2a-4706-a605-5f6a701b335b
Type:
Q1 - 1st Quarter - Report
Period:
2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 16, 2026 at 5:36 PM
Income:
$60,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Megan Herber
Registrant
FAEGRE DRINKER BIDDLE & REATH LLP

Law firm

Washington, District of Columbia
Client
TEVA PHARMACEUTICALS USA, INC.

Pharmaceutical manufacturer

New Jersey, United States of America
Lobbying Activities (2)
Activity 1
Copyright/Patent/Trademark

Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.

Lobbyists (2)
  • MEGAN SUSSMAN HERBER
  • MR. ELLIOT VICE
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
Activity 2
Health Issues

Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.

Lobbyists (2)
  • MEGAN SUSSMAN HERBER
  • MR. ELLIOT VICE
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)

Source: LDA.gov, data retrieved November 17, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.